| For: | Uppala PK, Karanam SK, Kandra NV, Edhi S. Lassa fever: A comprehensive review of virology, clinical management, and global health implications. World J Virol 2025; 14(3): 108405 [PMID: 41025087 DOI: 10.5501/wjv.v14.i3.108405] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v14/i3/108405.htm |
| Number | Citing Articles |
| 1 |
Opeyemi Hammed, Miracle Adesina, Busayo Buoye, Damilare Taiwo, Isaac Olufadewa, Dorcas Alabi. The persistence and mortality of Lassa fever in Nigeria reflect systemic clinical and diagnostic challenges rather than viral reemergence alone. Frontiers in Epidemiology 2026; 6 doi: 10.3389/fepid.2026.1837721
|
| 2 |
Paul M. Iziomo, Emmanuel Awosanya, Olalekan John Taiwo, Judah Moyin-Jesu, Gift Idumah, Samuel Ayanwale, Eniola Cadmus, Terese Gabriel Orum, Ogbonna Nwambeke, Victor Akinseye, Oyewale Tomori, Simeon Cadmus, Stephen Olaide Aremu. Temporal trends and epidemiological patterns of Lassa fever outbreaks in Ebonyi State, Nigeria: A retrospective study (2018–2023). PLOS Global Public Health 2026; 6(7) doi: 10.1371/journal.pgph.0006871
|
| 3 |
Sanchez-Lopez Sebastian, Cerino-Peñaloza Maria Susana, Padilla-Zambrano Huber Said, Brust Karen. Lessons in the Wake of a Lassa fever case in the Midwest U.S: epidemiology, management and preparedness gaps. BMC Infectious Diseases 2026; 26(1) doi: 10.1186/s12879-026-13875-6
|
| 4 |
Ayşegül Bülbül, Ateş Kara, Adil Denizli. Optical Biosensors for Viral Infectious Diseases: Current Roles and Future Perspectives. Biomedical Materials & Devices 2026; doi: 10.1007/s44174-026-00745-7
|
| 5 |
Chinwe Lucia Ochu, William Douglas Evans. Lassa viral dynamics: implications for missed diagnosis. The Lancet Infectious Diseases 2026; 26(5) doi: 10.1016/S1473-3099(25)00731-5
|
| 6 |
Joseph Odunayo Igbokwe, Elvis Efe Isere, Olubunmi Adeyemi, Aduragbemi Adebayo, Danny Asogun, Ayodeji Olayemi. Household practices associated with reported household Lassa fever occurrence in hyperendemic communities of Edo state, Nigeria. Discover Public Health 2026; 23(1) doi: 10.1186/s12982-026-02539-0
|
| 7 |
Yogitha Balasubramani, Gayathri Krishnakumar, Karthikeyan Elumalai. Therapeutic advances in Lassa fever: From ribavirin to mechanism-based antivirals and monoclonal antibody combinations. Decoding Infection and Transmission 2026; 4 doi: 10.1016/j.dcit.2026.100087
|
| 8 |
Ibrahima Sory Cherif, Esme Marie Laure Essis, Mamadou Alpha Diallo, Loukou Léandre Konan, Aly Antoine Kamano, Djoukou Olga Denise Kpebo, Seydou Dia, Mamadou Oury Baldé, Sory Condé, Fatoumata Cherif, Momory Millimono, Fanta Mady Kouyaté, Angelo Loua, Lila Condé, Priya Gusain. Missed Opportunities for Timely Diagnosis and Effective Therapeutic Management of Prolonged Fever: A Case Study of Confirmed Lassa Fever in N’Zérékoré, Guinea, 2022. Case Reports in Infectious Diseases 2026; 2026(1) doi: 10.1155/crdi/2672939
|
| 9 |
Akanbi-Hakeem Hauwa Bolanle, Mobolaji Abdulateef Ayoola, Shaaba Judah Egba, Terese Gabriel Orum, Ibrahim Yahaya, Hembafan Liz-marie Allam, Salawudeen Mukhtar Oluwasesan, Zachariya Esther. Abattoirs as sentinel sites for Lassa fever surveillance: A One Health perspective in West Africa. Journal of Interventional Epidemiology and Public Health 2026; 9(Suppl 12) doi: 10.37432/jieph-d-25-00317
|
| 10 |
Uwem Okon Edet, Clement Meseko, Md Zulfekar Ali, Edema Enogiomwan Imalele, Agusi Ebere Roseann, Aniekan-Augusta Okon Eyo, Bassey Edet, Olayinka Asala. Mapping the scientific landscape of Lassa virus: a 55-year bibliometric study (1970–2025). Science in One Health 2026; 5 doi: 10.1016/j.soh.2026.100156
|
| 11 |
Zubairu Iliyasu, Muhammad Sani Abubakar, Bilkisu Z. Iliyasu, Nafisa S. Nass, Aliyu T. Mande. Safety first, science second: Healthcare workers' conditional trust and willingness to participate in Lassa fever vaccine trials in Nigeria. Vaccine 2026; 92 doi: 10.1016/j.vaccine.2026.129162
|